[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Sun, Aug 23rd, 2026

Biotechnology Stocks

A list of publicly traded biotechnology and biotech-related stocks and ETFs.
Sun, Aug 23rd, 2026

Biotechnology (biotech) Stocks are publicly traded companies that develop pharmaceutical drugs used in the treatment of disease. You can use Barchart's Biotech Stocks list to find investment opportunities and compare stocks involved in this hot industry.

View Profiles of these companies.

Biotechnology Stocks News

Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News

Werewolf Therapeutics stock explodes higher on a merger agreement with Ambros Therapeutics. But is there any further upside left in HOWL shares?

HOWL : 0.8735 (+102.57%)
NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough

NVAX stock surges amid biotech stock rally following Moderna and Merck cancer breakthrough.

$NASX : 26,180.45 (+0.43%)
MRK : 152.55 (+2.39%)
NVAX : 8.94 (+6.18%)
MRNA : 145.13 (+8.86%)
XBI : 165.73 (+1.44%)
SNY : 45.85 (+1.55%)
BNTX : 116.57 (+5.12%)
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.

Achieve Life Sciences (ACHV) is a $685 million biotech focused on cytisinicline-based nicotine addiction treatments, showing strong recent technical momentum. ACHV has surged 173% over 52 weeks. Shares...

ACHV : 7.99 (-0.37%)
This Little-Known Biotech Stock Just Hit a New 5-Year High

Pulse Biosciences (PLSE) just hit a new 5-year high and has strong technical momentum. Shares are up more than 100% over the past 52 weeks. Revenue is projected to surge 652.38% this year and 236.71% next....

PLSE : 50.42 (+5.37%)
How AI-Driven Protein Generation Is a Margin Killer for Drugmakers

The next tech revolution in biotech might save lives, but it could also crush pharmaceutical margins.

GOOGL : 344.82 (+1.22%)
LLY : 1,255.40 (+0.88%)
NVS : 158.86 (+1.68%)
Short Sellers Are Betting Against UroGen Pharma Stock, But Wall Street Expects 263% Earnings Growth in 2027

UroGen Pharma (URGN) has surged nearly 180% over the past year and has strong technical momentum. URGN maintains a 100% “Buy” technical opinion from Barchart. The company’s revenue is projected to...

URGN : 46.86 (+0.13%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.